The global Circulating Tumor Cells (CTCs) market was USD 9.7 billion in 2022 and is expected to register a revenue CAGR of 11.5% during the forecast period.
The global Circulating Tumor Cells (CTCs) market was USD 9.7 billion in 2022 and is expected to register a revenue CAGR of 11.5% during the forecast period.